blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1125585

EP1125585 - TREATMENT OF GRAFT-VERSUS-HOST DISEASE TARGETING AILIM [Right-click to bookmark this link]
Former [2001/34]REMEDIES FOR IMMUNOLOGICAL DISEASES
[2010/41]
StatusNo opposition filed within time limit
Status updated on  01.06.2012
Database last updated on 06.07.2024
Most recent event   Tooltip17.05.2013Lapse of the patent in a contracting state
New state(s): LU		published on 19.06.2013  [2013/25]
Applicant(s)For all designated states
Japan Tobacco Inc.
2-1, Toranomon 2-chome, Minato-ku
Tokyo 105-8422 / JP
[2011/30]
Former [2001/34]For all designated states
Japan Tobacco Inc.
2-1, Toranomon 2-chome, Minato-ku
Tokyo 105-8422 / JP
Inventor(s)01 / TEZUKA, Katsunari Pha. Frontier Res.Lab. of Japan
Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku
Yokohama-shi, Kanagawa / JP
02 / WATANABE, Yoshihiro, Pha. Frontier Res. Lab. of
Japan Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku
Yokohama-shi, Kanagawa / JP
03 / ABE, Ryo
869-17, Higashifukai
Nagareyama-shi, Chiba 270-0101 / JP
 [2002/11]
Former [2001/34]01 / TEZUKA, Katsunari Pha. Frontier Res.Lab. of Japan
Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku
Yokohama-shi, Kanagaw / JP
02 / WATANABE, Yoshihiro, Pha. Frontier Res. Lab. of
Japan Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku
Yokohama-shi, Kanagaw / JP
03 / ABE, Ryo
869-17, Higashifukai
Nagareyama-shi, Chiba 270-0101 / JP
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2001/34]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date00956800.730.08.2000
[2001/34]
WO2000JP05868
Priority number, dateJP1999024267230.08.1999         Original published format: JP 24267299
JP2000025468024.08.2000         Original published format: JP 2000254680
[2001/34]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0115732
Date:08.03.2001
Language:EN
[2001/10]
Type: A1 Application with search report 
No.:EP1125585
Date:22.08.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2001 takes the place of the publication of the European patent application.
[2001/34]
Type: B1 Patent specification 
No.:EP1125585
Date:27.07.2011
Language:EN
[2011/30]
Search report(s)International search report - published on:JP08.03.2001
(Supplementary) European search report - dispatched on:EP26.07.2007
ClassificationIPC:C07K16/28, A61P37/06
[2010/41]
CPC:
A61K38/1709 (EP,US); A61K38/00 (KR); A61P1/16 (EP);
A61P19/02 (EP); A61P29/00 (EP); A61P37/00 (EP);
A61P37/06 (EP); C07K16/18 (EP,US); C07K16/2818 (EP,US);
A61K2039/505 (EP,US); C07K2317/73 (EP,US) (-)
Former IPC [2001/34]A61K45/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/34]
Extension statesAL17.05.2001
LT17.05.2001
LV17.05.2001
MK17.05.2001
RO17.05.2001
SI17.05.2001
TitleGerman:BEHANDLUNG DER TRANSPLANTAT-GEGEN-EMPFÄNGER-KRANKHEIT MIT AILIM ALS ZIEL[2011/30]
English:TREATMENT OF GRAFT-VERSUS-HOST DISEASE TARGETING AILIM[2010/41]
French:TRAITEMENT DE LA RÉACTION DE GREFFE CONTRE HÔTE EN CIBLANT AILIM[2010/41]
Former [2001/34]BEHANDLUNG VON ERKRANKUNGEN DES IMMUNSYSTEMS
Former [2001/34]REMEDIES FOR IMMUNOLOGICAL DISEASES
Former [2001/34]TRAITEMENTS DE MALADIES IMMUNITAIRES
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase17.05.2001Translation filed 
17.05.2001National basic fee paid 
17.05.2001Search fee paid 
17.05.2001Designation fee(s) paid 
17.05.2001Examination fee paid 
Examination procedure17.05.2001Amendment by applicant (claims and/or description)
17.05.2001Examination requested  [2001/34]
08.02.2008Despatch of a communication from the examining division (Time limit: M04)
18.06.2008Reply to a communication from the examining division
11.12.2008Despatch of a communication from the examining division (Time limit: M04)
17.04.2009Reply to a communication from the examining division
18.11.2009Despatch of a communication from the examining division (Time limit: M04)
29.03.2010Reply to a communication from the examining division
13.10.2010Communication of intention to grant the patent
01.04.2011Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
10.06.2011Fee for grant paid
10.06.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.02.2008
Opposition(s)02.05.2012No opposition filed within time limit [2012/27]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
10.06.2011Request for further processing filed
10.06.2011Full payment received (date of receipt of payment)
Request granted
28.06.2011Decision despatched
Fees paidRenewal fee
30.08.2002Renewal fee patent year 03
01.09.2003Renewal fee patent year 04
31.08.2004Renewal fee patent year 05
31.08.2005Renewal fee patent year 06
27.03.2006Renewal fee patent year 07
31.08.2007Renewal fee patent year 08
20.03.2008Renewal fee patent year 09
24.08.2009Renewal fee patent year 10
25.08.2010Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.07.2011
BE27.07.2011
CY27.07.2011
DK27.07.2011
FI27.07.2011
IT27.07.2011
NL27.07.2011
SE27.07.2011
IE30.08.2011
LU30.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR28.10.2011
ES07.11.2011
PT28.11.2011
[2013/25]
Former [2013/22]AT27.07.2011
BE27.07.2011
CY27.07.2011
DK27.07.2011
FI27.07.2011
IT27.07.2011
NL27.07.2011
SE27.07.2011
IE30.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR28.10.2011
ES07.11.2011
PT28.11.2011
Former [2012/35]AT27.07.2011
BE27.07.2011
CY27.07.2011
DK27.07.2011
FI27.07.2011
IT27.07.2011
NL27.07.2011
SE27.07.2011
IE30.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR28.10.2011
PT28.11.2011
Former [2012/31]AT27.07.2011
BE27.07.2011
CY27.07.2011
DK27.07.2011
FI27.07.2011
IT27.07.2011
NL27.07.2011
SE27.07.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR28.10.2011
PT28.11.2011
Former [2012/23]AT27.07.2011
BE27.07.2011
CY27.07.2011
FI27.07.2011
IT27.07.2011
NL27.07.2011
SE27.07.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR28.10.2011
PT28.11.2011
Former [2012/20]AT27.07.2011
BE27.07.2011
CY27.07.2011
FI27.07.2011
NL27.07.2011
SE27.07.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR28.10.2011
PT28.11.2011
Former [2012/18]AT27.07.2011
BE27.07.2011
CY27.07.2011
FI27.07.2011
NL27.07.2011
SE27.07.2011
MC31.08.2011
GR28.10.2011
PT28.11.2011
Former [2012/12]AT27.07.2011
BE27.07.2011
CY27.07.2011
FI27.07.2011
NL27.07.2011
SE27.07.2011
GR28.10.2011
PT28.11.2011
Former [2012/11]AT27.07.2011
BE27.07.2011
FI27.07.2011
NL27.07.2011
SE27.07.2011
GR28.10.2011
PT28.11.2011
Former [2012/10]BE27.07.2011
FI27.07.2011
NL27.07.2011
SE27.07.2011
GR28.10.2011
PT28.11.2011
Former [2012/09]BE27.07.2011
FI27.07.2011
NL27.07.2011
PT28.11.2011
Former [2012/08]NL27.07.2011
Documents cited:Search[Y]WO9830232  (ROBARTS JOHN P RES INST [CA], et al) [Y] 1-3,9-12 * page 7, line 5 - line 21; claims 1-4 *;
 [A]WO9852606  (BIOGEN INC [US], et al) [A] 6-8 * page 19 - page 26 *;
 [PX]EP0984023  (JAPAN TOBACCO INC [JP]) [PX] 1-3,9-12 * page 4, paragraph 26 - paragraph 27; claim 33 * * paragraph [0286] *;
 [Y]  - HUTLOFF ANDREAS ET AL, "ICOS is an inducible T-cell co-stimulator-structurally and functionally related to CD28", NATURE (LONDON), (19990121), vol. 397, no. 6716, ISSN 0028-0836, pages 263 - 266, XP002156736 [Y] 1-3,9-12 * the whole document *

DOI:   http://dx.doi.org/10.1038/16717
 [T]  - NURIEVA ROZA I ET AL, "Inducible costimulator is essential for collagen-induced arthritis.", THE JOURNAL OF CLINICAL INVESTIGATION. MAR 2003, (200303), vol. 111, no. 5, ISSN 0021-9738, pages 701 - 706, XP002336752 [T] 1-3,9-12 * the whole document *

DOI:   http://dx.doi.org/10.1172/JCI17321
 [T]  - IWAI HIDEYUKI ET AL, "Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 OCT 2002, (20021015), vol. 169, no. 8, ISSN 0022-1767, pages 4332 - 4339, XP002336753 [T] 1-3,9-12 * the whole document *
 [A]  - FABRIS C ET AL, "RELATIONSHIP AMONG HEPATIC INFLAMMATORY CHANGES, CIRCULATING LEVELSOF CYTOKINES, AND RESPONSE TO IFN-ALPHA IN CHRONIC HEPATITIS C", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, MARY ANN LIEBERT, NEW YORK, NY, US, (1998), vol. 18, no. 9, ISSN 1079-9907, pages 705 - 709, XP000929124 [A] 4,5 * abstract *
 [T]  - OZKAYNAK E ET AL, "Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.", NATURE IMMUNOLOGY JUL 2001, (200107), vol. 2, no. 7, ISSN 1529-2908, pages 591 - 596, XP008019252 [T] 6 * the whole document *

DOI:   http://dx.doi.org/10.1038/89731
 [T]  - NANJI S A ET AL, "Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival", TRANSPLANTATION PROCEEDINGS, ORLANDO, FL, US, (200311), vol. 35, no. 7, ISSN 0041-1345, pages 2477 - 2478, XP002288913 [T] 6 * abstract *

DOI:   http://dx.doi.org/10.1016/j.transproceed.2003.08.029
International search[X]WO9838216  (JAPAN TOBACCO INC [JP], et al);
 [X]WO9915553  (BUNDESREPUBLIK DEUTSCHLAND LET [DE], et al)
by applicant   - CELL, (1998), vol. 30, no. 9, pages 343 - 346
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.